Table 4. Initial chikungunya symptoms and baseline co-morbidities by gender.

Significant p-values after Bonferroni-adjustment are in bold.

Characteristic n (%)	Female (n=388)	Male (n=95)	p-value
Initial Symptoms
Muscle pain	377 (97%)	93 (98%)	0.99
Weakness	353 (91%)	73 (77%)	<0.0001
Joint pain and/or inflammation	383 (99%)	92 (97%)	0.19
Rash/itch	339 (87%)	69 (73%)	0.0004
Fever	304 (80%)	71 (76%)	0.49
Headache	291 (75%)	62 (65%)	0.06
Lymphadenopathy	287 (74%)	55 (58%)	0.002
Cool extremities	216 (56%)	40 (42%)	0.018
Nausea or vomiting	157 (41%)	21 (22%)	0.0004
Bruising	69 (18%)	7 (7%)	0.012
Hemorrhage	8 (2%)	3 (3%)	0.46
Nose bleed	3 (1%)	2 (2%)	0.25
Oral bleeding	4 (1%)	2 (2%)	0.34
Initial Rheumatic Symptoms
Wrist pain	347 (91%)	78 (85%)	0.10
Ankle pain	331 (86%)	80 (87%)	0.89
Finger pain	325 (85%)	77 (83%)	0.62
Elbow pain	329 (86%)	65 (71%)	0.0005
Toe pain	312 (82%)	74 (80%)	0.78
Knee pain	306 (80%)	76 (82%)	0.72
Hip pain	286 (75%)	55 (59%)	0.0022
Prior Comorbidities
Arthritis	9 (2%)	8 (9%)	0.009
Chronic foot pain	8 (2%)	6 (6%)	0.04
Gout	7 (2%)	5 (5%)	0.07
Osteoarthritis	10 (3%)	3 (3%)	0.73
Heart disease	10 (3%)	3 (3%)	0.73
Kidney disease	10 (3%)	2 (2%)	0.99
Lung disease	17 (4%)	2 (2%)	0.39
Diabetes	31 (8%)	3 (3%)	0.10
HTN	47 (12%)	10 (11%)	0.66
Depression	15 (4%)	5 (5%)	0.58

P<0.00167 required